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Abstract: 
 
 Enzymes that use distinct active site structures to perform identical reactions are known as 
analogous enzymes. The isolation of analogous enzymes suggests the existence of multiple 
enzyme structural pathways that can catalyze the same chemical reaction. A fundamental 
question concerning analogous enzymes is whether their distinct active-site structures would 
confer the same or different kinetic constraints to the chemical reaction, particularly with respect 
to the control of enzyme turnover. Here we address this question with the analogous enzymes 
of bacterial TrmD and its eukaryotic and archaeal counterpart Trm5. While both TrmD and Trm5 
catalyze methyl transfer to synthesize the m1G37 base at the 3' position adjacent to the tRNA 
anticodon, using S-adenosyl methionine (AdoMet) as the methyl donor, TrmD features a trefoil-
knot active-site structure whereas Trm5 features the Rossmann fold. Pre-steady-state analysis 
revealed that product synthesis by TrmD proceeds linearly with time, whereas that by Trm5 
exhibits a rapid burst followed by a slower and linear increase with time. The burst kinetics of 
Trm5 suggests that product release is the rate-limiting step of the catalytic cycle, consistent with 
the observation of higher enzyme affinities to the products of tRNA and AdoMet. In contrast, the 
lack of burst kinetics of TrmD suggests that its turnover is controlled by a step required for 
product synthesis. Although TrmD exists as a homodimer, it showed “half-of-the-sites” reactivity 
for tRNA binding and product synthesis. The kinetic differences between TrmD and Trm5 are 
parallel to those between the two classes of aminoacyl-tRNA synthetases, which use distinct 
active-site structures to catalyze tRNA aminoacylation. This parallel suggests that the findings 
have a fundamental importance for enzymes that catalyze both methyl and aminoacyl transfer 
to tRNA in the decoding process.  
 
 
Key words: Trm5, TrmD, burst kinetics, tRNA(m1G37), half-of-the-site reactivity.  
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Introduction 
 Enzymes use their active site structures to guide chemical conversion of substrates to 
products through several transition states. The unique local environments of each active site 
enforce specific orientations and conformations of the bound substrates to promote the 
chemical conversion, while also stabilizing the leaving groups in the formation of products. 
Enzymes that perform the same reaction usually share a highly conserved active site with 
sequence and structural features derived from the same evolutionary origin. However, 
exceptions to the rule exist, in which different active-site structures are recruited by enzymes of 
unrelated origins to catalyze the same chemical reaction 1. When analogous enzymes of distinct 
structures are employed for the same reaction, a fundamental question is whether the difference 
in structures would influence the control of reaction kinetics. Of interest is the determination of 
the slowest step in a catalytic cycle that regulates the timing of turnover, which is associated 
with the highest activation energy barrier in the reaction coordinate.  
 The TrmD and Trm5 enzymes form an exemplary pair of analogous enzymes for the same 
reaction 2; 3. These enzymes catalyze methyl transfer from the methyl donor AdoMet to the N1 
position of G37 to synthesize the modified m1G37 base 3' adjacent to the tRNA anticodon. 
TrmD is encoded by bacterial species and is characterized by an unusual AdoMet-binding fold 
that contains a rare protein subdomain known as the trefoil knot 4; 5; 6. In contrast, Trm5 is 
encoded by eukaryotic and archaeal species and is characterized by the widely popular protein 
fold known as the Rossmann fold for binding the methyl donor 3; 7; 8; 9. The Rossmann fold and 
the trefoil knot structure share no common structural or sequence motifs and represent 
unrelated protein families3; 5; 7. In addition, TrmD exists as a homodimer with the two active sites 
assembled at the dimer interface 4; 5, in which both monomers make substantial and 
interdigitating contributions to AdoMet binding. In contrast, Trm5 exists as a monomer and is 
active within a monomeric structure 3; 10. With respect to tRNA recognition, these two enzymes 
also adopt different strategies: while Trm5 requires the integrity of the tRNA L shape, TrmD 
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requires only a simple stem-loop structure mimicking the bottom half of the L shape 11. Although 
there are other analogous pairs of tRNA modification enzymes, such as the pair consisting of 
the bacterial TrmJ (with a trefoil knot structure) and the eukaryotic Trm7 (with the Rossmann 
fold) for synthesis of 2'-O-methylation at position 32 of the anticodon loop 12, the TrmD-Trm5 
pair is by far the best characterized.  
 The m1G37 modified base synthesized by TrmD and Trm5 is conserved in all three domains 
of life and is present in both the cytoplasm and mitochondria as one of the few tRNA 
modifications that are essential for growth 2; 13; 14; 15; 16. The m1G37 modification plays multiple 
and important roles in translation: it enhances aminoacylation by archaeal cysteinyl- and 
phosphoseryl-specific aminoacyl-tRNA synthetases (aaRSs) 17; 18, it prevents mis-charging of 
yeast tRNAAsp by ArgRS 19, and it accelerates entry of aminoacyl-tRNAs to the ribosome 20, 
while blocking frame-shifts of tRNA-ribosome complexes during translation 15; 21. The isolation of 
TrmD and Trm5 for the synthesis of m1G37 is significant, indicating the existence of separate 
structural pathways that arose early in evolution for the making of an essential modified base for 
tRNA maturation. Here, we use TrmD and Trm5 as examples of a pair of analogous enzymes to 
address how each controls the kinetics of the m1G37 synthesis reaction. We show that TrmD 
and Trm5 differ in the rate-limiting step of their catalytic cycle, and that their kinetic differences 
can be correlated with structural differences. Importantly, the structure-kinetic separation of 
TrmD from Trm5 is reminiscent of the previously observed separation between the two classes 
of aaRSs that catalyze aminoacyl transfer to tRNA 22. Thus, the results of this study will have 
impact on enzymes that catalyze both aminoacyl transfer and methyl transfer to tRNA during the 
process of decoding genetic information.  
 
Results  
 Separation of TrmD from Trm5 by pre-steady-state kinetics. We used E. coli TrmD and 
the archaeal Methanococcus jannaschii Trm5 as a representative pair for the synthesis of 
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m1G37. Both enzymes are well characterized by x-ray crystal structures to have distinct 
AdoMet-binding folds 5; 8; 9. In addition, the crystal structure of M. jannaschii Trm5 in complex 
with tRNA and AdoMet has recently been solved 9, which shows base flipping of G37 from the 
anticodon loop into the active-site pocket. This base flipping is a common feature of all nucleic 
acid modification enzymes for which crystal structures are available. In steady-state kinetics, E. 
coli TrmD and M. jannaschii Trm5 have similar values of Km with respect to both the tRNA and 
AdoMet substrates 3. However, the lack of differentiation in steady state does not mean that 
these two enzymes share a similar kinetic mechanism, because steady-state analysis does not 
resolve individual steps in a catalytic cycle. Indeed, a separate single-turnover analysis of M. 
jannaschii Trm5 has shown that the enzyme exhibits a faster rate of methyl transfer than the 
steady-state rate 7, indicating that the steady-state rate does not report on methyl transfer for 
this enzyme. To better explore the kinetic mechanism of TrmD and Trm5 and to gain insight into 
the meaning of the steady-state rate, we examined pre-steady-state kinetics for these two 
enzymes. Because the preference for tRNA sequences for each enzyme differs, we chose the 
unmodified transcript of E. coli tRNALeu as the substrate for TrmD and that of M. jannaschii 
tRNACys for Trm5, both of which are quantitatively modified by high concentrations of enzymes, 
indicating that they both have a well-folded structure 3; 23.  
 The pre-steady-state analysis was performed with saturating AdoMet relative to the Km of 
AdoMet for each enzyme. The tRNA substrate was maintained in a 10-fold molar excess of 
enzyme to permit one turnover of the reaction on the enzyme and subsequent steady-state 
synthesis. The amount of the m1G37-tRNA product synthesized was measured and calculated 
as the fraction (%) per active site of the enzyme. This analysis showed that while the synthesis 
of m1G37-tRNA by TrmD occurred in a time-dependent linear fashion, the synthesis by Trm5 
occurred in a rapid burst phase followed by a slower and linear phase (Fig.1), demonstrating 
that the two enzymes are kinetically distinct. Fitting the TrmD data to a linear equation revealed 
a slope of 0.090 ± 0.001 s-1, which is the value of kcat in steady state. Fitting the Trm5 data to a 
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burst equation revealed a rate constant of 0.12 ± 0.03 s-1 for the first turnover and a rate 
constant of 0.020 ± 0.007 s-1 for the steady-state kcat. The first turnover rate is defined as kchem, 
which is a measure of the chemical conversion in the methyl transfer reaction under conditions 
of rapid binding equilibria. These kchem and kcat values of Trm5 are similar to the values 
determined separately from single-turnover and from steady-state analysis 7. The observation of 
a kchem greater than kcat for Trm5 confirms that the steady-state kcat does not represent the event 
of methyl transfer, but rather a physical step after the transfer. The active fraction of Trm5 was 
estimated at 20% based on the amplitude of the burst (Fig.1); this corresponds closely to the 
previously reported plateau values for methyl transfer to the unmodified tRNA transcript 3. The 
low levels of active fraction may be due to heterologous expression of M. jannaschii Trm5 in E. 
coli.  
 Tight binding of Trm5 to products. The burst kinetics of Trm5 suggests that the release of 
reaction products is slow such that it limits the rate of enzyme turnover. This was evaluated by 
determining the enzyme affinity for each substrate relative to the product. A higher affinity to the 
product than to the substrate would support the notion of slow product release. The equilibrium 
constant Kd of Trm5 for the tRNA substrate was determined from single turnover kinetics with 
increasing concentrations of the enzyme. All time courses of methyl transfer showed single 
exponential kinetics (Fig.2A), confirming the rapid binding equilibria between the enzyme, tRNA 
and AdoMet. Fitting the data of rate as a function of Trm5 concentration to a hyperbolic equation 
yielded the maximum rate of 0.12 ± 0.02 s-1, consistent with the kchem measured from pre-
steady-state analysis, and an apparent Kd for the tRNA substrate of 0.7 ± 0.1 µM (Fig.2B), 
similar to the Kd reported previously 7.  
 The Kd of Trm5 for the m1G37-tRNA product was determined by treating the product as an 
inhibitor of the methyl transfer reaction. The m1G37-tRNA product was synthesized from the 
methyl transfer reaction and was purified away from the unreacted substrate by a previously 
developed method 24. It was used to form a series of Trm5-product complexes that was assayed 
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for the m1G37 synthesis activity in pre-steady-state kinetics. While increasing concentration of 
the product had little effect on the rate of the burst or steady-state phase, it progressively 
decreased the amplitude of the burst phase (Fig.2C), indicating that the dissociation of the 
product from Trm5 was slow such that it limited the availability of the enzyme for the methyl 
transfer reaction. A fit of the data to a quadratic equation yielded a Kd of 0.2 ± 0.1 µM of the 
enzyme-product complex (Fig.2D), lower than the Kd (0.7 ± 0.1 µM) of the enzyme-substrate 
complex by 3-4-fold. This result demonstrates the tight binding affinity of Trm5 for the m1G37-
tRNA product.  
 The methyl transfer reaction converts AdoMet to S-adenosyl homocysteine (AdoHcy). The 
Kd constants of the enzyme for AdoMet and AdoHcy were determined to address the affinity for 
each. The Kd for AdoMet was determined by formation of a series of Trm5-AdoMet complexes 
that was used to monitor the m1G37 synthesis reaction in pre-steady state. As the AdoMet 
concentration increased, the amplitude of the burst phase also increased (Fig.3A), indicating the 
enzyme dependence on AdoMet binding for the methyl transfer activity. Fitting the amplitude 
data as a function of AdoMet concentration to a hyperbolic equation revealed a Kd of 0.44 ± 0.09 
µM for AdoMet (Fig.3B). Determination of Kd for AdoHcy was determined similarly to that for the 
m1G37-tRNA product. A series of Trm5-AdoHcy complexes was preformed and used to inhibit 
the m1G37 synthesis reaction. While the increase in the concentration of AdoHcy had little 
effect on the burst or steady-state rate, it progressively decreased the amplitude of the burst 
phase (Fig.3C). Fitting the amplitude data vs. the concentration of AdoHcy to a hyperbolic 
equation revealed a Kd of 20 ± 5 nM (Fig.3D), which is nearly 20-fold lower than the Kd of 0.44 ± 
0.09 µM for AdoMet (Fig.3B), demonstrating the preferential tight binding of Trm5 to AdoHyc 
than to AdoMet. In fact, analysis of the Kd values of the two products reveals that Trm5 affinity 
for AdoHcy is higher than that for the m1G37-tRNA product (Kd = 0.2 ± 0.1 µM) by 20-fold, 
indicating a specific role of AdoHcy in product release.  
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 Kinetics of TrmD and stoichiometry of product formation. The lack of burst kinetics of 
TrmD suggests that the steady-state turnover rate kcat is not limited by product release. To better 
understand the meaning of kcat, the rate of methyl transfer was measured from single turnover 
kinetics. All time courses of m1G37 synthesis showed single exponential kinetics (Fig.4A), 
indicating that the formation of TrmD-tRNA-AdoMet complexes was in rapid equilibrium binding 
and that the kinetics of the reaction was not limited by binding but by the rate of methyl transfer. 
Fitting the data of rate as a function of the TrmD dimer concentration to a hyperbolic equation 
revealed the maximum rate constant kchem of 0.090 ± 0.003 s-1 (Fig.4B), virtually identical to the 
kcat determined in pre-steady state (Fig.1). Thus, the steady-state kcat of TrmD is defined by the 
rate of methyl transfer. An active-site titration of TrmD revealed that the dimer was 72 ± 5 % 
active (Supplementary information, Fig.S1), which was used to correct the enzyme 
concentration in single turnover kinetics. From the titration of rate vs. concentration, a Kd of 0.44 
± 0.09 µM for the TrmD-tRNA complex was identified (Fig.4B), well within the physiological 
concentrations of tRNA. All of the kinetic parameters for TrmD and Trm5 obtained here are 
summarized in Table 1.  
 Because TrmD functions as a dimer, the stoichiometry of m1G37 synthesis is of interest. 
This was determined by measuring the amount of m1G37 synthesis per TrmD dimer at the time 
point that allowed one turnover (11 sec). A saturating concentration of tRNA relative to the Kd 
(tRNA) was used to react with a series of high concentrations of TrmD dimer to establish rapid 
equilibrium binding. Analysis of the synthesis of m1G37-tRNA as a function of TrmD dimer 
revealed two phases of linear relationships (Fig.5). The first phase was observed under 
conditions where tRNA was in excess of the TrmD dimer and the slope of this phase was 0.93. 
Thus, despite the molar excess of tRNA relative to the enzyme dimer, each dimer synthesized 
approximately only one m1G37 on tRNA in one turnover. This unexpected result suggests that 
TrmD exhibits “half-of-the-sites” reactivity in which only one of the two active sites is functional 
at a given time. If both active sites were to function equivalently at the same time, then each 
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dimer should have synthesized two molecules of the product. The second linear phase in the 
titration was observed under conditions where enzyme was in excess of tRNA. The slope of this 
linear phase (0.34) was less than one, which was expected because each dimer can react with 
less than one tRNA in conditions of limiting concentrations of tRNA.  
 Fluorescence analysis of substrate binding to TrmD. To determine the molecular basis 
for the half-of-the-sites reactivity of TrmD, the binding stoichiometries for AdoMet and tRNA 
were determined by equilibrium titrations of intrinsic tryptophan fluorescence. For measurement 
of AdoMet binding, the fluorescence was excited at 295 nm and the emission was monitored at 
310-400 nm. Because AdoMet binding showed little absorption at either wavelength, the peak of 
each emission (at 330 nm) was recorded directly and corrected for dilution. Titration of TrmD 
with increasing concentrations of AdoMet showed that the binding progressively quenched the 
intrinsic fluorescence and that fitting the data to a quadratic binding equation yielded a Kd of 1.1 
± 0.2 µM for the methyl donor (Fig.6A). The stoichiometry of AdoMet binding was then 
determined by using a high concentration of TrmD relative to the Kd (AdoMet) to drive the 
binding interaction. Analysis of the fluorescence data vs. the molar ratio of AdoMet relative to 
the dimer revealed a biphasic quenching curve (Fig.6B), in which the first phase of quenching 
was steep and linear with respect to the molar ratio up to the value of 2, while the second phase 
was flat and independent of the increase in molar ratio. The value of 2 in the first phase 
indicates that, in the absence of tRNA, each TrmD dimer is capable of binding two molecules of 
AdoMet, which is consistent with the finding in crystal structures of TrmD and suggests that the 
dimer is symmetrical with respect to AdoMet binding. The flat second phase indicates that, once 
the stoichiometry of 2 is reached, there is no further binding of AdoMet to the enzyme.  
 For measurement of tRNA binding, quenching of intrinsic tryptophan fluorescence was also 
observed and the data was similarly recorded as in the case of AdoMet, except that the 
magnitude of each emission peak (at 330 nm) was corrected for dilution and for inner filter 
effect, due to absorption of tRNA at the excitation and emission wavelengths. Fitting the 
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fluorescence quenching data to a quadratic equation yielded a Kd of 0.30 ± 0.03 µM for tRNA 
(Fig.6C), similar to the value obtained by kinetics (Fig.4B). The stoichiometry of tRNA binding 
was then determined by using a high concentration of TrmD relative to the Kd (tRNA) to drive 
the binding interaction. Analysis of fluorescence data as a function of the molar ratio of tRNA to 
the dimer also revealed a biphasic quenching curve (Fig.6D). The initial quenching was steep 
and linear with respect to the molar ratio up to the value of 1, which was followed by a much 
flatter second phase. These data indicate that each TrmD dimer can specifically bind only one 
tRNA, and that the further fluorescence quenching at higher tRNA concentrations is probably 
due to non-specific binding interactions. The stoichiometry of one tRNA binding per dimer is 
consistent with the stoichiometry of methyl transfer. Thus, while the two subunits of TrmD can 
both simultaneously bind AdoMet, only one can bind tRNA at a time to perform the methyl 
transfer reaction.  
 The fluorescene titration method was also used to determine TrmD affinities for the products 
AdoHcy and m1G37-tRNA. Binding of AdoHcy to TrmD dimer under a condition similar to that of 
AdoMet binding revealed quenching of the intrinsic fluorescence (Fig.6E). Fitting the 
fluorescence quenching data vs. AdoHcy concentration to a quadratic equation revealed a Kd of 
0.33 ± 0.04 µM, indicating a 3-4-fold higher affinity relative to the Kd of 1.1 ± 0.2 µM for AdoMet. 
However, this 3-4-fold higher affinity is smaller in magnitude than the 20-fold higher affinity in 
the case of Trm5 with respect to binding AdoHcy vs. AdoMet. Interestingly, for the m1G37-tRNA 
product, while fluorescence quenching was also observed upon binding of this product, a fit of 
the fluorescence quenching data (after correction of inner filter effect) vs. the concentration of 
m1G37-tRNA to a quadratic equation revealed a Kd of 40 ± 2 nM, indicating a ~10-fold higher 
affinity relative to the Kd of 0.30 ± 0.03 µM for tRNA. The fluorescence binding Kd values for both 
substrates and products of TrmD are summarized in Table 1.  
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Discussion 
 Distinct kinetic control of catalytic cycle by TrmD and Trm5. The goal of this study was 
to address the question of whether enzymes with distinct structural folds would impose the 
same or different control of their catalytic cycle for the same chemical reaction. Using TrmD and 
Trm5 as an exemplary pair, we examined their control of the catalytic cycle by pre-steady-state 
kinetics and applied the rate constant kchem to encompass all of the steps required for product 
synthesis and the constant kcat for those involved in product release. For the m1G37 synthesis 
reaction, kchem includes the terms for substrate binding, active site rearrangement, base flipping 
of G37, deprotonation of N1 of G37, and methyl transfer to N1 from AdoMet, whereas kcat also 
includes the terms for breakdown of the ternary complex with m1G37-tRNA and AdoHcy and 
the release of products from the enzyme. Here we show that Trm5 exhibits burst kinetics and 
that it has preferential binding affinities to the reaction products relative to the respective 
substrates, indicates that this enzyme uses the rate-limiting product release step to control its 
catalytic cycle. In contrast, we show that TrmD lacks the burst kinetics and that it exhibits 
identical rates for the synthesis and release of products, indicating that this enzyme uses the 
rate-limiting product synthesis to control its catalytic cycle. Thus, the two enzymes exert 
different kinetic controls of their catalytic cycle.  
 The distinction between TrmD and Trm5 is reminiscent of the distinction between the two 
classes of aaRSs in both structure and kinetics. The family of aaRSs includes the 20 canonical 
enzymes, each of which uses the energy of ATP hydrolysis to activate an amino acid substrate 
and to transfer the activated aminoacyl-adenylate to the 3' end of cognate tRNAs to synthesize 
aminoacyl-tRNAs as substrates for protein synthesis 25. Class I aaRSs bind ATP in the 
Rossmann fold, whereas class II aaRSs bind ATP in a non-Rossmann fold created by the 
interface of oligomeric subunits (typically homodimers). Such class-specific structural features of 
aaRSs are recognizable in ways that separate TrmD from Trm5 and are directly relevant to the 
spatial binding of ATP or AdoMet, which share in common an adenosine moiety that is likely to 
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provide fundamental constraints in the rate of chemical conversion and the rate of catalytic 
turnover. Indeed, structural analysis of these enzymes has consistently shown that enzymes of 
the same active-site structure bind AdoMet (Fig.7A,B) or ATP (Fig.7C,D) in a similar 
conformation. Specifically, the Rossmann fold in methyl transferases binds AdoMet in an 
extended conformation with a degree of 160-180o for the C4'-C5'-Sδ-Cγ dihedral angle (Fig.7A) 
8; 9
, similar to the extended conformation of ATP in the Rossmann fold of aaRSs (Fig.7C) 26. In 
contrast, the non-Rossmann fold in methyl transferases binds AdoMet in a bent conformation 
with an ~80o degree of the dihedral angle mentioned above (Fig.7B), similar to the bent 
conformation of ATP in the non-Rossmann fold of aaRSs (Fig.7D) 27. In parallel, kinetic analysis 
has consistently shown that enzymes of the Rossmann-fold active site exhibit burst kinetics, 
such as class I aaRSs22, while enzymes of the non-Rossmann fold active site assembled at the 
interface of oligomeric subunits lack burst kinetics, such as class II aaRSs22; 28; 29. Together, 
these results form a large database to unite enzymes of diverse functions (methyl transfer and 
aminoacyl transfer) to derive a model for correlating structure with kinetics. This model proposes 
that the extended conformation of AdoMet or ATP in the Rossmann fold favorably positions the 
relevant reactive groups for facile chemical conversion involving bond breaking and bond 
formation to occur. This leaves open a suitable approach for the deprotonated nucleophile of the 
target base to the methyl group of AdoMet in the methyl transfer reaction or the deprotonated α-
phosphate to the carbonyl group of ATP in the aminoacylation reaction. In contrast, the bent 
conformation of AdoMet or ATP in the non-Rossmann fold does not leave such access for the 
incoming nucleophile. The facile structural environment to promote chemistry in the Rossmann 
fold has been previously noted by structural and kinetic analysis for class I aaRSs 22, whereas 
the requirement of structural re-organization prior to chemistry in the non-Rossmann fold has 
also been noted for class II aaRSs 28; 29. Broad support for the model is the observation that, 
while Trm5 is the first Rossmann-fold RNA methyl transferase to be characterized kinetically, 
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several DNA methyl transferases with the same fold also show burst kinetics and slow product 
release 30; 31; 32; 33. However, exceptions to the rule might exist, but detailed structural and kinetic 
analysis must be performed to address how the exceptions occur. For example, SepRS is a 
tetramer that uses a non-Rossmann fold active site to catalyze aminoacylation of tRNACys with 
phosphoserine to synthesize sep-tRNACys as an intermediate in the pathway for cys-tRNACys 
biosynthesis 34. SepRS exhibits burst kinetics 18, indicating an exception to the no-burst rule of 
non-Rossmann enzymes, but the basis for the exception is not known, because there is no 
structural data showing the geometry of the ATP bound in the active site 35; 36. Thus, it is 
important to recognize that, while further data are needed to address possible exceptions, the 
proposed model serves as a useful foundation to relate how each structure confers the specific 
kinetic property.  
 Product release from Trm5. Burst kinetics has been used as a tool to measure the 
affinities of Trm5 to AdoMet and tRNA, and to the respective products of these substrates. The 
advantage of this method is that the binding of substrates to Trm5 was fast and under the 
diffusion control so that the reaction kinetics could be used to monitor the extent of binding. 
Another advantage is that affinities were measured in the catalytically competent state of Trm5 
during the reaction of methyl transfer. The observation that Trm5 binds with a 3-4 fold higher 
affinity to m1G37-tRNA relative to tRNA, and with a ~20-fold higher affinity to AdoHcy relative to 
AdoMet, is consistent with the existence of a highly stable ternary product complex of the 
enzyme with m1G37-tRNA and AdoHcy, which is slow to release the products. Of significance is 
the particularly tight binding of Trm5 to AdoHcy (Kd = 20 nM), indicating that the release of this 
product is the dominant factor in the overall catalytic turnover. A similar case is found in the 
related DNA methyl transferase M.HhaI (responsible for synthesis of m5C in DNA), where the 
release of AdoHcy is the slowest in the catalytic cycle and it occurs before the release of the 
methylated DNA product 37; 38, indicating that as soon as AdoHcy is released, the release of the 
nucleic acid product quickly follows. This order of release is likely to apply to Trm5 as well.  
14 
 A possible rationale for the dominance of AdoHcy in the Trm5 turnover is discernable by 
biochemical and structural analysis of the enzyme. The recent ternary complex of Trm5 with 
AdoMet and tRNA reveals that the methyl donor is tightly bound in the active site (Fig.7A) 9, 
where the adenine ring and the ribose 2'- and 3'-OH groups of the adenosine moiety are each 
anchored by conserved motifs of the Rossmann fold (such as D223, I224, D251, and F203), 
while the carboxyl and amino groups of the methionine moiety are each stabilized by 
interactions with N265 and P267 of the catalytic NLP loop (analogous to the NPPY loop of other 
Rossmann-fold enzymes 39). It is in this intimate interaction network that AdoMet is positioned 
for methyl transfer to generate AdoHcy. Superposition of the ternary structure of Trm5 with a 
binary structure 8 bound to the analog sinefungin reveals a major difference in the ordering of 
the K137-R147 loop, which moves in closer to the bound AdoMet in the tertiary complex (by ~2 
Å) and helps to stabilize the flipped-in G37 base. The structural change of the loop is important 
in the ternary complex to enforce tighter interactions with the methyl donor, and is consistent 
with the observed affinity improvement of AdoMet to Trm5 in the presence of tRNA (Kd = 0.44 
µM, Table 1) than in the absence of tRNA (Kd = 3.1 µM) as determined previously 7. The 
conformation change of the K137-R147 loop in the active-site by the presence of tRNA is 
coupled with distal induced-fit movements, including the enzyme contacts with the tRNA tertiary 
core and those with the D and anticodon stem-loop backbone groups 9, suggesting that the 
binding of the entire tRNA is optimized to position the catalytic NLP loop to “lock” on the methyl 
donor. Importantly, in the related Rossmann-fold structures of M.HhaI methyl transferase, the 
structurally stabilized enzyme lock on AdoMet is essentially unchanged as AdoMet is converted 
to AdoHcy 40; 41; 42, even though the stereochemical position of the lock can change in the course 
of methyl transfer. This provides insight into how the enzyme structure is designed to lock on 
virtually all parts of the AdoMet molecule (both the adenosine and methionine moieties) such 
that the release of AdoHcy after methyl transfer would be the most critical step in the breakdown 
of the product complex.  
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 Product synthesis by TrmD. The determination that TrmD exhibits identical rate constants 
kchem and kcat (Table 1) indicates that the methyl transfer event on the enzyme is slow relative to 
product release such that kchem dominates kcat. A key feature of the methyl transfer by TrmD is 
the half-of-the-sites reactivity, where although both active sites of the homodimeric enzyme are 
capable of binding AdoMet, only one binds tRNA and only one catalyzes methyl transfer (Fig.6). 
The origin of the half-of-the-sites reactivity is not known at present, due to the lack of tRNA-
bound crystal structure. Note that while the two active sites of TrmD are identical upon AdoMet 
or AdoHcy binding in binary crystal structures of TrmD4; 5, this symmetry may result from crystal 
packing forces and does not exclude the possibility of a pre-existing asymmetry prior to tRNA 
binding. Alternatively, the half-of-the-sites reactivity may arise during tRNA binding to a pre-
existing symmetric dimer to the highly interdigitating and expansive interface of the two 
monomers (accounting for 26% of the total surface per monomer), which may form the binding 
surface for the G37 base and may be constructed in such a way to allow only one tRNA to bind 
to one subunit or alternatively bind across the dimer interface, leading to the stoichiometry of 
one tRNA bound per dimer. Half-of-the-sites activity has been previously shown for dimeric and 
tetrameric aaRSs of both the Rossmann-fold and the non-Rossmann-fold type 17; 28; 29; 43; 44; 45. 
The discovery of half-of-the-sites reactivity for TrmD suggests that this phenomenon may be 
general to multimeric enzymes that operate on tRNA. 
 The structural basis for the tRNA-induced asymmetry of TrmD cannot be resolved by the 
present data and further experiments are necessary. One possibility of the asymmetry is an 
oscillating model, in which the two active sites are both active and the one with the bound G37 
of tRNA catalyzes methyl transfer and the synthesis of m1G37-tRNA on the subunit activates 
the second subunit to bind to a new G37 in a different tRNA, which then triggers the release of 
the m1G37-tRNA product from the first subunit. The Kd values determined from fluorescence 
titration are consistent with some aspects of this oscillating model, showing that a TrmD dimer 
binds the m1G37-tRNA product with a ~10-fold higher affinity (Kd = 40 ± 2 nM) relative to the 
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affinity for the tRNA substrate (Kd = 0.3 ± 0.03 µM) (Fig.6C, F). Because the catalytic cycle of 
TrmD is not limited by product release, the tight binding of the m1G37-tRNA product on one 
subunit can serve to activate the second subunit to bind to a new tRNA substrate. Note that 
because the fluorescence analysis presented here was performed with just the enzyme-product 
or enzyme-substrate complexes, it cannot be used to determine the enzyme-product affinity 
upon binding of a second molecule of substrate. New fluorescence tools are being developed to 
address the dynamics of the two subunits in the oscillating model. Other possibilities of the 
asymmetry of TrmD also exist. For example, a variation of the oscillating model is that the one 
subunit with the bound G37 of tRNA does not catalyze methyl transfer but moves the nucleic 
acid substrate to the second active site to perform methyl transfer. Alternatively, the two active 
sites can be unequal upon tRNA binding and only one of the two is active for methyl transfer.  
 Implications for biology. This study demonstrates that the analogous enzymes TrmD and 
Trm5 control their catalytic cycle by distinct kinetic steps that are directly related to their unique 
active-site structures. While TrmD controls its catalytic cycle by the rate of methyl transfer, Trm5 
controls the cycle by coordinating the release of AdoHcy. The specific control may serve a 
useful biological function for each enzyme. For example, the half-of-the-sites reactivity of TrmD 
can be considered an extreme case of negative cooperativity, as has been suggested for 
dimeric aaRSs that exhibit this property 46. The half-of-the-sites reactivity of TrmD occurs at the 
tRNA binding step, suggesting that the negative cooperativity between the two subunits with 
respect to tRNA binding would confer the enzyme a high sensitivity to intracellular changes of 
tRNA concentrations, such as those occurring in stress conditions that can drastically curtail 
biosynthesis of tRNA 47. Because TrmD is proposed to act early in the pathway of tRNA 
maturation (due to its ability to synthesize m1G37 without complete folding of tRNA) 9, this 
innate sensitivity to reduced tRNA levels in stress conditions can help to establish an early 
decision point to arrest the m1G37 synthesis and to terminate the maturation pathway so as to 
eliminate the cellular expenditure for further modification reactions. Conversely, the kinetic 
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control of Trm5 in product release is relevant to the utility of the m1G37-tRNA product as the 
obligate precursor for synthesis of the complex wybutosine base in tRNAPhe at the 37 position 48. 
The slow product release by Trm5 may be a strategy to protect the m1G37-tRNA product and to 
channel it to the downstream enzyme in the wybutosine biosynthesis pathway. Similar models 
for the channeling are the two-step reaction pathways that synthesize certain aminoacyl-tRNAs 
by the action of two enzymes 18; 49, where the aaRS for the first reaction delays product release 
and facilitate product transfer to the second enzyme in order to promote rapid production of the 
end product. Importantly, the wybutosine modification in tRNAPhe is conserved in eukaryotes and 
archaea but is absent from bacteria, consistent with the biological distribution of Trm5 and 
supporting a role of Trm5 in the biosynthesis pathway of the modification.  
 
18 
Methods 
 Material preparation. E. coli TrmD with an N-terminal His tag and M. jannaschii Trm5 with a 
C-terminal His tag were expressed and purified as described 3; 23. Transcripts of E. coli tRNALeu 
and M. jannaschii tRNACys were prepared and purified as described 11. [3H-methyl]-AdoMet was 
purchased from Perkin Elmer (NET155H, 70.8 Ci/mmol).  
 Kinetic assays. The synthesis of m1G37-tRNA by M. jannaschii Trm5 was performed at 55 
oC in a buffer containing 100 mM Tris-HCl, pH 8.0, 4 mM DTT, 0.1 mM EDTA, 6 mM MgCl2, 100 
mM KCl, and 0.024 mg/mL BSA. The synthesis by E. coli TrmD was performed at 37 oC in the 
same buffer except for the substitution of 100 mM KCl with 24 mM NH4Cl. The tRNA substrate 
was heat-denatured at 85 oC for 3 min and annealed at 37 oC for 15 min before use. Pre-steady-
state and single turnover experiments were monitored upon rapid mixing of 15 µL of enzyme in 
one syringe with 15 µL of a mixture of annealed tRNA and 3H-AdoMet in the second syringe on 
the RQF-3 rapid quench instrument (KinTek Corp, Texas). The reaction was quenched with 54 
µL of 5% trichloroacetic acid (TCA) and an aliquot of 20 µL was spotted on a Whatman filter 
pad, which was washed several times with 5% TCA, dried, and counted in a scintillation 
counter. The 3H-m1G37-tRNA precipitated on the filter pad was determined and quantified.  
 Burst kinetics. Pre-steady-state kinetics of m1G37-tRNA synthesis was monitored upon 
rapid mixing of enzyme (1 µM) in one syringe with an annealed tRNA (10 µM) and 3H-AdoMet 
(50 µM) in the second syringe on the RQF-3 instrument. Data of Trm5 were fit to the burst 
equation: tEkeAyy o
tk
o ××+−×+=
×−
2)1( 1 , where yo is the y intercept, A is the amplitude of 
the initial exponential phase, k1 is the apparent rate constant of the initial exponential 
regression, k2 is the apparent rate constant of the steady-state phase, and t is the time in 
seconds 22; 50. 
Single turnover kinetics. Single turnover kinetics was performed by rapid mixing of 
enzyme (2-25 µM) in one syringe with tRNA (0.25 µM) and AdoMet (25 µM) in the second 
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syringe. Data were fit to the single exponential equation: )1( tko appeAyy ×−−×+= , where yo is 
the y intercept, A is the scaling constant, kapp is the apparent rate constant, and t is the time in 
seconds to determine kapp 22; 50. Control experiments confirmed that the mixing order of enzyme, 
tRNA, and AdoMet does not affect the rate of methyl transfer. The data of kapp vs. enzyme 
concentration for single turnover analysis of m1G37-tRNA synthesis were fit to the hyperbolic 
equation: )/( doochem KEEky +×= , where kchem is the rate constant for the chemistry step, and 
Eo is the enzyme concentration 22; 50.  
Measurement of Kd for m1G37-tRNA. Measurement of the Kd for m1G37-tRNA was 
obtained by pre-steady-state analysis, in which a series of enzyme (1 µM)-product (0-1.5 µM) 
complexes (preformed at 37 oC, 30 min) in one syringe was rapidly mixed with tRNA (annealed 
at 37 oC, 15 min) and AdoMet (50 µM) in the second syringe to initiate the m1G37 synthesis 
reaction. Data of the burst amplitude as a function of the product tRNA was fit to a quadratic 
equation: 
o
ododo
o E
IEKIEKIE
yyy
×
××−++−++
×∆−=
2
4)()( 2
 
where yo is the initial amplitude without the inhibitor m1G37-tRNA, ⊗y is the scaling constant for 
amplitude change, Eo is the initial enzyme concentration, I is the concentration of m1G37-tRNA 
22; 50
. 
Measurement of Kd for AdoMet. Measurement of the Kd for AdoMet was obtained by pre-
steady-state analysis, in which a series of enzyme (5 µM)-AdoMet (0.5-20 µM) complexes (at 37 
oC, 30 min) in one syringe was rapidly mixed with tRNA (annealed at 37 oC, 15 min) in the 
second syringe to initiate the m1G37 synthesis reaction. Data of the burst amplitude as a 
function of AdoMet concentration was fit to the hyperbolic equation: )/( dKSSAy +×= ; where 
A is maximum amplitude in burst kinetics, S is the AdoMet concentration 22; 50. 
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 Measurement of Kd for AdoHcy. Measurement of the Kd for AdoHcy was obtained by pre-
steady-state analysis, in which a series of enzyme (5 µM)-AdoHcy (10-200 nM) complexes (at 
37 oC, 30 min) in one syringe was rapidly mixed with tRNA (annealed at 37 oC, 15 min) and 
AdoMet (25 µM) in the second syringe to initiate the m1G37 synthesis reaction. Data of the 
burst amplitude as a function of AdoHcy was fit to the hyperbolic 
equation: )/( do KIIAyy +×−= ; yo is the initial burst amplitude in the absence of AdoHcy; A 
is the scaling constant  for amplitude change upon addition of AdoHcy; I is the concentration of 
AdoHcy 22; 50.  
 Active site titration and stoichiometry of methyl transfer. Enzyme (100 nM) in one 
syringe was rapidly mixed with tRNA (10-300 nM) and AdoMet (30 µM, specific activity 1990 
dpm/pmol) in the second syringe in a total volume of 20 µL to initiate methyl transfer. An aliquot 
of the reaction (15 µL) was quenched by acid after the time period that allowed for one cycle of 
methyl transfer (11 sec) and was analyzed by a scintillation counter to determine the amount of 
m1G37-tRNA synthesis. The data were fit to the following equation to derive the active fraction:  
2
4)()( 2 SEKSEKSE
y ododo
××−++−++
= , where y represents the methylated tRNA 
product after one turnover; Eo is the active enzyme concentration; S is the tRNA concentration; 
Kd is the dissociation constant for tRNA 22; 50.  
 The stoichiometry of methyl transfer was determined by rapid mixing of active enzyme dimer 
(0, 0.36, 0.72, 1.08, 1.44, 1.8, 2.16, 3.6, 5.76, and 9.0 µM) in one syringe with tRNA (5 µM) and 
AdoMet (30 µM, 1900 dpm/pmol) in the second syringe on the RFQ-3 instrument in a time 
course up to 55 sec. The progress curve of the synthesis of m1G37-tRNA synthesis at 0, 1, 3, 6, 
9, 10, 11, 12, 16, 20, 30, 40, and 55 sec was sampled and fit to the hyperbola for single turnover 
kinetics (see above). The amount of m1G37-tRNA synthesis at 11 sec was determined from the 
progress curve and plotted as a function of the dimer concentration.  
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 Fluorescence titration experiments. The stoichiometry of TrmD binding to substrates and 
products was determined by monitoring the quenching of intrinsic tryptophan fluorescence. The 
fluorescence was excited at 295 nm and the emission was monitored from 304 nm to 400 nm at 
room temperature in a buffer containing 100 mM Tris-HCl, pH 8.0, 100 mM KCl, 0.1 mM EDTA, 
6 mM MgCl2, and 4 mM DTT. For Kd measurements, TrmD was at 0.2 µM and AdoMet and 
AdoHcy were both titrated in the range of 0.1-40 µM. while the tRNALeu transcript was titrated in 
the range of 0.1-6 µM. For measurement of the Kd of m1G37-tRNA, the product tRNA was 
synthesized and purified by a previously developed method 24 and was titrated in the range of 
0.011-0.6 µM against 0.05 µM TrmD. The data were fit to the quadratic equation using 
Kaleidagraph: 
o
ododo
o E
SEKSEKSE
FFF
×
××−++−++
×∆−=
2
4)()( 2
, where F is the measured 
fluorescence signal; Fo stands for the initial fluorescence before the addition of enzyme; ∆F 
represents the scale of fluorescence signal change; Eo is the initial enzyme concentration; S is 
the tRNA or AdoMet concentration 22; 50. For stoichiometry determination, AdoMet was titrated in 
the range of 0-103 µM for TrmD dimer (10 µM), and tRNA was titrated in the range 0-12.4 µM 
for TrmD dimer (2.9 µM). For analysis of the stoichiometry of AdoMet, the emission peak at 330 
nm was recorded and corrected for dilution. For analysis of the stoichiometry of tRNA, the 
emission peak at 330 nm was corrected additionally for inner filter effect, according to the 
formula, )2/)log(( 330295 AAantiFF obsc +×= .  
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Figure Legends 
Figure 1. Pre-steady-state analysis of m1G37-tRNA synthesis of TrmD and Trm5. (A) Time 
course of m1G37-tRNA synthesis was determined by mixing E. coli TrmD (1 µM) with E. coli 
tRNALeu (10 µM) and AdoMet (30 µM) at 37°C. The time dependence of product formation, 
calculated as the amount of synthesis per active site of the enzyme (%), was fit to a linear 
equation to derive kcat. (B) Time course of m1G37-tRNA synthesis was performed at 55°C as in 
(A) with M. jannaschii Trm5 (1 µM), M. jannaschii tRNAcys (10 µM), and AdoMet (25 µM). The 
data was fit to a burst equation by non-linear regression to derive kchem and kcat.  
 
Figure 2. Determination of tRNA parameters of Trm5. (A) Single turnover kinetics of the m1G37 
synthesis reaction at 55°C performed at the indicated concentrations of M. jannaschii Trm5 with 
tRNA (0.25 µM) and AdoMet (25 µM). (B) Plot of the rate vs. concentration data fit to a 
hyperbolic equation to derive kchem and Kd for tRNA. (C) Pre-steady-state kinetics of the m1G37 
synthesis reaction by M. jannaschii Trm5 (1 µM)-m1G37-tRNA (0-1.5 µM) complexes with tRNA 
(10 µM) and AdoMet (50µM). (D) Plot of the rate vs. concentration data fit to a quadratic 
equation to derive Kd for m1G37-tRNA. 
 
Figure 3. Determination of AdoMet parameters of Trm5. (A) Pre-steady-state kinetics of the 
m1G37 synthesis reaction by rapidly mixing M. jannaschii Trm5 (5 µM)-AdoMet (0.4-9.6 µM) 
complexes with tRNA (15 µM). (B) Plot of the rate vs. concentration data of (A) fit to a hyperbolic 
equation to derive the Kd for tRNA. (C) Pre-steady-state kinetics of the m1G37 synthesis 
reaction by rapidly mixing M. jannaschii Trm5 (5 µM)-AdoHcy (0-0.2 µM) complexes with tRNA 
(15 µM) and AdoMet (25 µM). (D) Plot of the data of (C) fit to a hyperbolic equation to derive Kd 
for AdoHcy. 
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Figure 4. Single turnover kinetics of TrmD. (A) Single turnover kinetics of the m1G37 synthesis 
reaction at 37°C performed at the indicated concentrations of E. coli TrmD with tRNA (0.25 µM) 
and AdoMet (30 µM). (B) Plot of the rate vs. concentration data fit to a hyperbolic equation to 
derive the kchem of the reaction and the Kd for tRNA.  
 
Figure 5. Stoichiometry of methyl transfer of TrmD. The amount of m1G37-tRNA synthesis was 
measured at 37°C in single turnover conditions, where saturating tRNA (5 µM) and AdoMet (30 
µM) were rapidly mixed with TrmD dimer (active concentration 0.36-9 µM). The reaction was 
acid quenched at 11 seconds. The amount of product formed was plotted against the active 
concentration of TrmD dimer, generating two linear fits with slopes of 0.93 and 0.33, 
respectively. The inflection point occurred at a ratio of 1 of tRNA:TrmD dimer. 
 
Figure 6. Determination of substrate stoichiometry of TrmD. (A) Quenching of intrinsic 
tryptophan fluorescence of TrmD by AdoMet binding with emission scans shown in inset. A 
quadratic fit of quenching (at 330 nm) vs. AdoMet concentration revealed a Kd of 1.1 ± 0.2 µM. 
(B) Determination of the stoichiometry of AdoMet by tryptophan fluorescence quenching. (C) 
Quenching of intrinsic tryptophan fluorescence of TrmD by tRNA binding with emission scans 
shown in inset. A quadratic fit of quenching (at 330 nm) vs. tRNA concentration revealed a Kd of 
0.3 ± 0.03 µM. (D) Determination of the stoichiometry of tRNA by tryptophan fluorescence 
quenching. (E) Quenching of intrinsic tryptophan fluorescence of TrmD by AdoHcy binding with 
emission scans shown in inset. A quadratic fit of quenching (at 330 nm) vs. AdoHcy 
concentration revealed a Kd of 0.33 ± 0.04 µM. (F) Quenching of intrinsic tryptophan 
fluorescence of TrmD by binding of m1G37-tRNA with emission scans shown in inset. A 
quadratic fit of quenching (at 330 nm) vs. tRNA concentration revealed a Kd of 40 ± 2 nM. Error 
bars represent ± SD from two to three independent titrations. 
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Figure 7. Active-site structural similarities between AdoMet-dependent methyl transferases and 
ATP-dependent aminoacyl-tRNA synthetases. (A) Active site of M. jannaschii Trm5 in complex 
with AdoMet (PDB ID:2ZZN) 9. (B) Active site of Haemophilus influenzae TrmD in complex with 
AdoMet (PDB ID:1UAK) 4. (C) Active site of the class I E. coli GlnRS in complex with ATP 
complex (PDB ID:1GTR) 26. (D) Active site of the class II Pyrococcus kodakaraensis AspRS in 
complex with a U-shaped ATP (PDB ID:1B8A) 51. All structures show the conserved residues 
that stabilize the specific conformation of the cofactor, which exhibits an extended conformation 
in (A) and (C) and in a U-shaped conformation in (B) and (D).  
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Table 1. Parameters of the synthesis of m1G37-tRNA 
 kchem 
(sec-1) 
kcat 
(sec-1) 
Kd (tRNA) 
(µM) 
Kd (m1G37-
tRNA) 
(µM) 
Kd 
(AdoMet) 
(µM) 
Kd (AdoHcy) 
(µM) 
Trm5 (K) 0.12 ± 0.02 0.020 ± 0.007 0.7 ± 0.1 0.2 ± 0.1 0.44 ± 0.09 0.020 ± 0.005 
TrmD (K) 0.090 ± 0.003 0.090 ± 0.001 0.44 ± 0.04    
TrmD (F)   0.30 ± 0.03 0.04 ± 0.002 1.1 ± 0.2 0.33 ± 004 
 
E. coli TrmD and M. jannaschii Trm5 were analyzed for kinetic parameters at 37 oC and 55 oC, 
respectively, for the reaction of synthesis of m1G37 on E. coli tRNALeu and M. jannaschii 
tRNACys. The reported values represent the mean ± SD of at least two independent 
measurements. Note that values in the rows of Trm5 (K) and TrmD (K) were obtained from 
kinetic analysis, while those in the row of TrmD (F) were obtained by fluorescence titration of 
binding analysis.  
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